138 related articles for article (PubMed ID: 25161016)
1. A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data.
Litton E; Eastwood GM; Bellomo R; Beasley R; Bailey MJ; Forbes AB; Gattas DJ; Pilcher DV; Webb SA; McGuinness SP; Saxena MK; McArthur CJ; Young PJ
Crit Care Resusc; 2014 Sep; 16(3):158-63. PubMed ID: 25161016
[TBL] [Abstract][Full Text] [Related]
2. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
[TBL] [Abstract][Full Text] [Related]
3. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
4. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
5. Stress Ulcer Prophylaxis in Cardiac Surgery: A Retrospective Cohort Study to Analyze the Effects of SUP Cessation.
Mekhail A; Young P; Mekhail AM; Tinawi G; Haran C; Clayton N; Galvin S
J Intensive Care Med; 2023 Oct; 38(10):917-921. PubMed ID: 37093762
[TBL] [Abstract][Full Text] [Related]
6. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
[TBL] [Abstract][Full Text] [Related]
7. Pneumonia prevention in intubated patients given sucralfate versus proton-pump inhibitors and/or histamine II receptor blockers.
Grindlinger GA; Cairo SB; Duperre CB
J Surg Res; 2016 Dec; 206(2):398-404. PubMed ID: 27884335
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
MacLaren R; Campbell J
Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
[TBL] [Abstract][Full Text] [Related]
11. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
12. A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the ICU.
Boyd C; Hassig T; MacLaren R
Pharmacotherapy; 2021 Oct; 41(10):820-827. PubMed ID: 34478588
[TBL] [Abstract][Full Text] [Related]
13. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review.
Krag M; Perner A; Wetterslev J; Møller MH
Acta Anaesthesiol Scand; 2013 Aug; 57(7):835-47. PubMed ID: 23495933
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of proton pump inhibitors versus histamine-2 receptor blockers in the cardiac surgical population: insights from the PEPTIC trial.
van Diepen S; Coulson T; Wang X; Opgenorth D; Zuege DJ; Harris J; Agyemang M; Niven DJ; Bellomo R; Wright SE; Young PJ; Bagshaw SM;
Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35213716
[TBL] [Abstract][Full Text] [Related]
15. Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries.
Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; McArthur C; Cook D; Nielsen N; Pelosi P; Keus F; Guttormsen AB; Moller AD; Møller MH;
Acta Anaesthesiol Scand; 2015 May; 59(5):576-85. PubMed ID: 25880349
[TBL] [Abstract][Full Text] [Related]
16. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
17. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
Barbateskovic M; Marker S; Granholm A; Anthon CT; Krag M; Jakobsen JC; Perner A; Wetterslev J; Møller MH
Intensive Care Med; 2019 Feb; 45(2):143-158. PubMed ID: 30680444
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
MacLaren R; Kassel LE; Kiser TH; Fish DN
Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
[TBL] [Abstract][Full Text] [Related]
19. Stress ulcer prophylaxis in critically ill adult patients with sepsis at risk of gastrointestinal bleeding: a retrospective cohort study.
Huang M; Han M; Song Z; Kuang L
Intern Med J; 2023 Mar; 53(3):389-396. PubMed ID: 34697866
[TBL] [Abstract][Full Text] [Related]
20. [Benefits and risks of stress ulcer prevention with proton pump inhibitors for critical patients: an observational cohort study with 1 972 patients].
Sun J; Wang B; Cao P; Zhu H; Lu K; Geng P; Tan D
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 May; 31(5):539-544. PubMed ID: 31198136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]